Company Filing History:
Years Active: 2023
Title: Michael Andrew Dillon: Innovator in Antibody Development
Introduction
Michael Andrew Dillon is a notable inventor based in San Francisco, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies.
Latest Patents
Dillon holds a patent for "Anti-Ly6G6D antibodies and methods of use." This patent provides innovative methods for utilizing anti-Ly6G6D antibodies, which target the lymphocyte antigen 6 complex, locus G61. His work in this area has the potential to advance therapeutic applications in immunology.
Career Highlights
Michael Dillon is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on developing medicines for serious diseases. His role at Genentech allows him to work at the forefront of scientific research and innovation.
Collaborations
Dillon collaborates with talented colleagues, including WeiYu Lin and Christoph Spiess. These partnerships enhance the research environment and contribute to the advancement of their projects.
Conclusion
Michael Andrew Dillon's work in antibody development exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for new therapeutic strategies in the medical field.